Projo 7 to 7 News Blog

By Marley Seaman
AP Health Writer

NEW YORK -- The Federal Trade Commission is investigating some of CVS Caremark Corp.'s business practices, the company said Thursday.

The Woonsocket-based drugstore chain and pharmacy benefits manager did not disclose the details of the "nonpublic investigation," but said it has not violated any antitrust laws. CVS suggested the FTC inquiry is connected to complaints made by the Change to Win coalition of labor unions. Change to Win has said CVS Caremark's size and buying power is bad for consumers, and accused CVS of a stocking expired products and violating patients' privacy, among other issues.

Change to Win also opposed CVS' acquisition of Longs Drugs Stores last year. CVS said the turmoil began in early 2007, when the coalition began trying to unionize CVS employees.

"We think there are serious issues with the company," Change to Win spokesman Ahmer Qadeer told The Associated Press. "We think there's a real question of priv acy problems, how they may use patient data, and real questions with this business model."

CVS reported its third-quarter results on Thursday, and also said the Caremark pharmacy benefits management unit has lost billions of dollars in contracts in recent months, which will keep the company from reaching its profit expectations in 2010. In afternoon trading, the stock sank $7.29, or 20.2 percent, to $28.85.

 Tags  Change to Win CVS Caremark Corp. Federal Trade Commission

Leave a comment

Please be civil. Vicious comments, personal attacks and profanity won't be published. Name and email are required; email address will not publish.

Name:

Email:

URL:  

Remember personal info?

Captcha:

Type the characters you see in the picture above.